Siemens Healthineers (SHL) Stock Price, News & Analysis

Company Overview

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers worldwide. It operates through four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment provides magnetic resonance imaging, computed tomography, X-ray systems, molecular imaging, and ultrasound systems. Its Diagnostics segment offers in-vitro diagnostic products and services to healthcare providers in laboratory and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment provides cancer care technologies, solutions, and services to oncology departments in hospitals and clinics; and technology-enabled optimized workflows, clinical services, and digital solutions and applications for managing treatment and therapy. Its Advanced Therapies segment offers products that are designed to support image-guided minimally invasive treatments in various areas, such as cardiology, interventional radiology, and surgery; and angiography systems and mobile C-arms. It offers essential technical customer service, such as maintenance and repair; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as digital healthhcare consulting, products, and services. The company is headquartered in Forchheim, Germany. Siemens Healthineers AG operates as a subsidiary of Siemens Aktiengesellschaft.

Key Stats

• Today's Range: €52.26 to €53.84
• 50-Day Range: €49.13 to €54.10
• 52-Week Range: €45.51 to €58.14
• Volume: 712,849 shs
• Average Volume: N/A
• Market Capitalization: $60.23 billion
• P/E Ratio: 32.40
• Dividend Yield: 1.77%
• Price Target: N/A
• Consensus Rating: N/A

SHL Stock Analysis - Frequently Asked Questions

How have SHL shares performed this year?

Siemens Healthineers' stock was trading at €51.20 at the beginning of 2025. Since then, SHL stock has increased by 5.0% and is now trading at €53.78.
View the best growth stocks for 2025 here.

What other stocks do shareholders of Siemens Healthineers own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Siemens Healthineers investors own include QUALCOMM (QCOM), Applied Materials (AMAT), Boeing (BA), Bristol-Myers Squibb (BMY), Netflix (NFLX), NVIDIA (NVDA) and Adobe (ADBE).

Industry, Sector and Symbol

• Stock Exchange: ETR
• Sector: Medical
• Industry: Medical Devices
• Sub-Industry: N/A
• Current Symbol: ETR:SHL
• CUSIP: N/A
• CIK: N/A
• Web: www.healthcare.siemens.de
• Phone: 49 69 6682 6602
• Fax: N/A
• Employees: 71,800
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): €1.66
• Trailing P/E Ratio: 32.40
• Forward P/E Ratio: 19.40
• P/E Growth: 1.16
• Net Income: $1.86 billion
• Net Margins: 8.43%
• Pretax Margin: N/A
• Return on Equity: 10.57%
• Return on Assets: 3.69%

Debt

• Debt-to-Equity Ratio: 92.22
• Current Ratio: 1.27
• Quick Ratio: 0.71

Sales & Book Value

• Annual Sales: $22.09 billion
• Price / Sales: 2.73
• Cash Flow: €1.38 per share
• Price / Cash Flow: 38.96
• Book Value: €16.33 per share
• Price / Book: 3.29

Miscellaneous

• Outstanding Shares: 1,120,000,000
• Free Float: N/A
• Market Cap: $60.23 billion
• Optionable: Not Optionable
• Beta: 0.70